INNPF OTC
INNOCAN PHARMA Corp
1W: -20.0%
1M: -5.4%
3M: -68.2%
YTD: -80.6%
1Y: -80.8%
3Y: -88.5%
5Y: -94.7%
$1.40
-0.22 (-13.58%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$2M
+59.6% ▲
Capital Expenditures
$15K
+67.4% ▲
5Y CAGR: +10.8%
Free Cash Flow
-$2M
+59.6% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
$1M
+205.7% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$10M | -$10M | -$4M | -$5M | -$262K |
| Depreciation & Amort. | $40K | $43K | $35K | $34K | $33K |
| Stock-Based Comp. | $527K | $2M | $967K | $854K | $2M |
| Change in Working Capital | $474K | -$969K | -$531K | -$808K | -$1M |
| Other Non-Cash Items | -$24K | -$83K | $125K | $716K | -$2M |
| Operating Cash Flow | -$4M | -$7M | -$6M | -$4M | -$2M |
| — Investing Activities — | |||||
| Capital Expenditures | $0 | -$41K | -$26K | -$46K | -$15K |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | -$7K | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | $0 | -$62 | -$5K | -$38K | $69K |
| Investing Cash Flow | $0 | -$48K | -$31K | -$84K | $54K |
| — Financing Activities — | |||||
| Net Debt Issuance | -$39K | -$38K | -$11K | -$22K | -$22K |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $1M | $11M | $136K | $3M | $2M |
| Financing Cash Flow | $4M | $15M | $125K | $3M | $3M |
| Net Change in Cash | $365K | $9M | -$6M | -$1M | $1M |
| Cash End of Period | $2M | $11M | $5M | $4M | $5M |
| Free Cash Flow | -$4M | -$7M | -$6M | -$4M | -$2M |